Monitoring chronic headache and medication-overuse headache prevalence in Denmark
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Objectives: To study chronic headache and medication-overuse headache (MOH) prevalence; to identify groups with high prevalence of these conditions; and to identify the most frequently used pain medications among respondents with chronic headache. Background: Chronic headache and MOH prevalence in Denmark were last estimated in 2010. Methods: In this cross-sectional study, 104,950 individuals aged ≥16 years were randomly sampled for the 2017 Danish Capital Region Health Survey. Responses to questions about headache and use of acute pain medications were linked to demographic registries. MOH was defined as headache ≥15 days/month plus self-report of use of pain medications ≥10 or 15 days/month, in the last three months. Weighted prevalence proportions were calculated. Results: Among 55,185 respondents, chronic headache prevalence was 3.0% (95% CI: 2.3–3.2) and MOH prevalence was 2.0% (95% CI: 1.8–2.1). Both conditions were more common among females and the middle-aged. Respondents on social welfare or receiving early retirement pensions had the highest prevalences. Among those with chronic headache, 44.7% overused over-the-counter analgesics for headache; paracetamol 41.5%; a combination of different pain relievers 25.3%; ibuprofen 21.9%; opioids 17.0%; combination preparations 14.3%; and triptans 9.1%. Conclusions: The highest prevalence of chronic headache and MOH was seen among people with low socioeconomic position. Overuse of paracetamol was most common. Reported opioid use was higher than expected. Groups with high prevalence of MOH should be the focus of public health interventions on rational use of OTC and prescription pain medications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
The Danish Civil Registration System
Pedersen, C. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,632 · cited 2×
“Researchers did not have access to the reference database containing individual identities (39,40).”
BackgroundMethodIndicators of socioeconomic position (part 1): Figure 1
Galobardes, B., Shaw, M., Lawlor, D. A., Lynch, J. W., & Davey Smith, G. (2006) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2004.023531 · Cited by 2,867 · cited 1×
“Socioeconomic position (SEP) is a term that describes social and economic factors that ‘‘influence what positions individuals or groups hold within the structure of a society’’ and describes a range of ‘‘exposures, resources, and susceptibilities that may affect health’’ (42).”
BackgroundThe Danish National Prescription Registry
Wallach Kildemoes, H., Toft Sørensen, H., & Hallas, J. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394717 · Cited by 2,467
Stovner, L. J., Nichols, E., Steiner, T. J., Abd-Allah, F., Abdelalim, A., Al-Raddadi, R. M., Ansha, M. G., Barac, A., Bensenor, I. M., Doan, L. P., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30322-3 · Cited by 1,908
Measuring the global burden of disease
Murray, C. J. L., & Lopez, A. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1201534 · Cited by 1,818 · cited 2×
“The Global Burden of Disease (GBD) studies show that headaches are among the top causes of disability, calculated from an estimate of degree of disability, and years of life lived with short- or long-term health loss (1,2).”
BackgroundThygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum-Hansen, H. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811399956 · Cited by 1,084 · cited 2×
“These 12-digit numbers were used consistently to link data from the DK-CRHS to national registers with information on age, sex, ethnicity, educational attainment, work status, and income (40).”
BackgroundMethodEpidemiology of Chronic Daily Headache in the General Population
Castillo, J., Muñoz, P., Guitera, V., & Pascual, J. (1999) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1999.3903190.x · Cited by 714
Migraine is first cause of disability in under 50s: will health politicians now take notice?
Steiner, T. J., Stovner, L. J., Vos, T., Jensen, R., & Katsarava, Z. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0846-2 · Cited by 642
Self-citationPrevalence of headache in Europe: a review for the Eurolight project
Stovner, L. J., & Andree, C. (2010) · The Journal of Headache and Pain · doi:10.1007/s10194-010-0217-0 · Cited by 580 · cited 1×
“Are opioids being prescribed inappropriately for headache, similar to trends for other chronic non-cancer pain conditions? Are opioids worsening the condition of people prone to headache who are being treated with opioids for other forms of chronic pain (58,59)? The proportion of the sample population who reported tri…”
BackgroundPathways between socioeconomic determinants of health
Lahelma, E., Martikainen, P., Laaksonen, M., & Aittomäki, A. (2004) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2003.011148 · Cited by 489 · cited 1×
“These specific aspects of SEP were considered as having independent and related effects as determinants of health (43).”
BackgroundThe impact of headache in Europe: principal results of the Eurolight project
Steiner, T. J., Stovner, L. J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Tassorelli, C., Barré, J., et al. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-31 · Cited by 382 · cited 4×
“7% of females) reported loss of 20 days in the previous three months (8).”
BackgroundResultInfluentialThe Prevalence and Burden of Primary Headaches in China: A Population‐Based Door‐to‐Door Survey
Yu, S., Liu, R., Zhao, G., Yang, X., Qiao, X., Feng, J., Fang, Y., Cao, X., He, M., & Steiner, T. (2012) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.02061.x · Cited by 367
Chronic daily headache in Chinese elderly: Prevalence, risk factors, and biannual follow-up
Wang, S.-J., Fuh, J.-L., Lu, S.-R., Liu, C.-Y., Hsu, L.-C., Wang, P.-N., & Liu, H.-C. (2000) · Neurology · doi:10.1212/wnl.54.2.314 · Cited by 271
Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life
Colás, R., Muñoz, P., Temprano, R., Gómez, C., & Pascual, J. (2004) · Neurology · doi:10.1212/01.wnl.0000120545.45443.93 · Cited by 264
Chronic Daily Headache in Taipei, Taiwan: Prevalence, Follow-Up and Outcome Predictors
Lu, S.-R., Fuh, J.-L., Chen, W.-T., Juang, K.-D., & Wang, S.-J. (2001) · Cephalalgia · doi:10.1046/j.1468-2982.2001.00294.x · Cited by 254 · cited 1×
“As in several other studies, MOH prevalence was highest among women and the middle-aged (13,18,23,25,26).”
Resulton behalf of the European Headache Federation School of Advanced Studies (EHF-SAS), Dresler, T., Caratozzolo, S., Guldolf, K., Huhn, J.-I., Loiacono, C., Niiberg-Pikksööt, T., Puma, M., Sforza, G., Tobia, A., et al. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0988-x · Cited by 243
The prevalence of primary headache disorders in Russia: A countrywide survey
Ayzenberg, I., Katsarava, Z., Sborowski, A., Chernysh, M., Osipova, V, Tabeeva, G., Yakhno, N., Steiner, T., & Burden, O. B. O. L. T. (2012) · Cephalalgia · doi:10.1177/0333102412438977 · Cited by 227
Prevalence of headache in an elderly population: attack frequency, disability, and use of medication
Prencipe, M. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.3.377 · Cited by 214
The Danish National Health Survey 2010. Study design and respondent characteristics
Christensen, A. I., Ekholm, O., Glümer, C., Andreasen, A. H., Hvidberg, M. F., Kristensen, P. L., Larsen, F. B., Ortiz, B., & Juel, K. (2012) · Scandinavian Journal of Public Health · doi:10.1177/1403494812451412 · Cited by 211 · cited 7×
“The main results of the DNHS are publicly available online www.danskernessundhed.dk (in Danish).”
BackgroundInfluentialSteiner, T. J., Gururaj, G., Andrée, C., Katsarava, Z., Ayzenberg, I., Yu, S.-Y., Al Jumah, M., Tekle-Haimanot, R., Birbeck, G. L., Herekar, A., et al. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-3 · Cited by 204 · cited 6×
“The latest GBD analyses for migraine and TTH also found that a country’s social development index (a compound measure based on income per capita, education, and fertility) is not a major determinant of the size of headache burden (7).”
BackgroundInfluentialSelf-citationErtas, M., Baykan, B., Kocasoy Orhan, E., Zarifoglu, M., Karli, N., Saip, S., Onal, A. E., & Siva, A. (2012) · The Journal of Headache and Pain · doi:10.1007/s10194-011-0414-5 · Cited by 200
Headache and comorbidity in children and adolescents
Bellini, B., Arruda, M., Cescut, A., Saulle, C., Persico, A., Carotenuto, M., Gatta, M., Nacinovich, R., Piazza, F. P., Termine, C., et al. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-79 · Cited by 198 · cited 1×
“In studies that used specific headache disorders as the index condition, associations between chronic headache and a range of disorders were shown (61,62).”
BackgroundHagen, K., Linde, M., Steiner, T. J., Stovner, L. J., & Zwart, J.-A. (2012) · Pain · doi:10.1016/j.pain.2011.08.018 · Cited by 178 · cited 3×
“6%) is similar to the 2012 report from Norway (12%) (23).”
BackgroundResultAaseth, K., Grande, R., Kvárner, K., Gulbrandsen, P., Lundqvist, C., & Russell, M. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01577.x · Cited by 166
Straube, A., Pfaffenrath, V, Ladwig, K.-H., Meisinger, C., Hoffmann, W., Fendrich, K., Vennemann, M., & Berger, K. (2010) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01906.x · Cited by 156
Westergaard, M. L., Glümer, C., Hansen, E. H., & Jensen, R. (2014) · Pain · doi:10.1016/j.pain.2014.07.002 · Cited by 155 · cited 3×
“CPR: Central Person Registry; CRS: Civil Registration System; DK-CRHS: Danish Capital Region Health Survey; DNHS: The Danish National Health Survey; DNPR: Danish National Prescription Registry; GBD: Global Burden of Disease; LTB: Lifting The Burden: The Global Campaign against Headache; MOH: Medication-overuse headach…”
Self-citationAnalgesic overuse among subjects with headache, neck, and low-back pain
Zwart, J. A., Dyb, G., Hagen, K., Svebak, S., Stovner, L. J., & Holmen, J. (2004) · Neurology · doi:10.1212/01.wnl.0000123262.96132.fc · Cited by 145
Primary headache disorders in the Republic of Georgia: Prevalence and risk factors
Katsarava, Z., Dzagnidze, A., Kukava, M., Mirvelashvili, E., Djibuti, M., Janelidze, M., Jensen, R., Stovner, L. J., & Steiner, T. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34abb · Cited by 140
Self-citationHeadache disorders and public ill-health in India: prevalence estimates in Karnataka State
Kulkarni, G. B., Rao, G. N., Gururaj, G., Stovner, L. J., & Steiner, T. J. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0549-x · Cited by 126 · cited 1×
“A study from India showed the opposite trend, with the lowest prevalence among the middle-aged (31).”
BackgroundEpidemiology of medication overuse headache in the general Swedish population
Jonsson, P., Hedenrud, T., & Linde, M. (2011) · Cephalalgia · doi:10.1177/0333102411410082 · Cited by 126 · cited 5×
“MOH prevalence in Denmark is higher than in Sweden (1.8”
ResultInfluentialChronic Frequent Headache in the General Population: Prevalence and Associated Factors
Wiendels, N., Knuistingh Neven, A., Rosendaal, F., Spinhoven, P., Zitman, F., Assendelft, W., & Ferrari, M. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01210.x · Cited by 125 · cited 1×
“Similar findings have been described among migrants to other European countries – Sweden (25), the Netherlands (16), and Germany (47) – compared to the local population.”
ResultKurita, G. P., Sjøgren, P., Juel, K., Højsted, J., & Ekholm, O. (2012) · Pain · doi:10.1016/j.pain.2012.07.023 · Cited by 122 · cited 1×
“2% among individuals with chronic pain (48).”
Herekar, A. D., Ahmad, A., Uqaili, U. L., Ahmed, B., Effendi, J., Alvi, S. Z., Shahab, M. A., Javed, U., Herekar, A. D., Khanani, R., et al. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0734-1 · Cited by 92 · cited 1×
“In Nepal (33) and Pakistan (35), the oldest age group had the highest prevalence.”
BackgroundLinde, M., Stovner, L. J., Zwart, J.-A., & Hagen, K. (2011) · Cephalalgia · doi:10.1177/0333102410391488 · Cited by 91
The prevalence of primary headache disorders in Ethiopia
Zebenigus, M., Tekle‐Haimanot, R., Worku, D. K., Thomas, H., & Steiner, T. J. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0704-z · Cited by 87
Birke, H., Kurita, G. P., Sjøgren, P., Højsted, J., Simonsen, M. K., Juel, K., & Ekholm, O. (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12700 · Cited by 76 · cited 1×
“Are opioids being prescribed inappropriately for headache, similar to trends for other chronic non-cancer pain conditions? Are opioids worsening the condition of people prone to headache who are being treated with opioids for other forms of chronic pain (58,59)? The proportion of the sample population who reported tri…”
BackgroundChronic Headache and Comorbibities: A Two‐Phase, Population‐Based, Cross‐Sectional Study
Da Silva Jr, A., Costa, E. C., Gomes, J. B., Leite, F. M., Gomez, R. S., Vasconcelos, L. P., Krymchantowski, A., Moreira, P., & Teixeira, A. L. (2010) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01620.x · Cited by 75
The prevalence of primary headache disorders in Nepal: a nationwide population-based study
Manandhar, K., Risal, A., Steiner, T. J., Holen, A., & Linde, M. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0580-y · Cited by 73 · cited 1×
“In Nepal (33) and Pakistan (35), the oldest age group had the highest prevalence.”
BackgroundThe Comorbidity of Headache With Other Pain Syndromes
Scher, A. I., Stewart, W. F., & Lipton, R. B. (2006) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00584.x · Cited by 72 · cited 1×
“In studies that used specific headache disorders as the index condition, associations between chronic headache and a range of disorders were shown (61,62).”
BackgroundRastenytė, D., Mickevičienė, D., Stovner, L. J., Thomas, H., Andrée, C., & Steiner, T. J. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0759-5 · Cited by 69 · cited 1×
“Our results support the findings of the Eurolight studies (8,36), which showed that useful time lost was substantial for those with probable MOH.”
ResultLong‐term opioid therapy in Denmark: A disappointing journey
Birke, H., Ekholm, O., Sjøgren, P., Kurita, G. P., & Højsted, J. (2017) · European Journal of Pain · doi:10.1002/ejp.1053 · Cited by 66 · cited 1×
“Are opioids being prescribed inappropriately for headache, similar to trends for other chronic non-cancer pain conditions? Are opioids worsening the condition of people prone to headache who are being treated with opioids for other forms of chronic pain (58,59)? The proportion of the sample population who reported tri…”
BackgroundNational awareness campaign to prevent medication-overuse headache in Denmark
Carlsen, L. N., Westergaard, M. L., Bisgaard, M., Schytz, J. B., & Jensen, R. (2017) · Cephalalgia · doi:10.1177/0333102417736898 · Cited by 55 · cited 3×
“A public health education campaign was carried out in Denmark based on the results of the earlier prevalence study (37).”
BackgroundInfluentialSelf-citationChronic Migraine and Medication-Overuse Headache Through the Ages
Boes, C. J., & Capobianco, D. J. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2005.00868.x · Cited by 46 · cited 1×
“Causation in MOH is probably best illustrated by the early work of clinicians who described patients increasingly disabled by headaches despite aggressive use of pain medications, but who improved when these medications were discontinued (53).”
BackgroundKavuk, I., Weimar, C., Kim, B., Gueneyli, G., Araz, M., Klieser, E., Limmroth, V, Diener, H., & Katsarava, Z. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01186.x · Cited by 46 · cited 1×
“Similar findings have been described among migrants to other European countries – Sweden (25), the Netherlands (16), and Germany (47) – compared to the local population.”
ResultShahbeigi, S., Fereshtehnejad, S., Mohammadi, N., Golmakani, M. M., Tadayyon, S., Jalilzadeh, G., & Pakdaman, H. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1200-0 · Cited by 45
Westergaard, M. L., Hansen, E. H., Glümer, C., & Jensen, R. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1858-3 · Cited by 42
Self-citationRueda-Sánchez, M., & Díaz‐Martínez, L. A. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01499.x · Cited by 39
Medicine use for headache in adolescence predicts medicine use for headache in young adulthood
Andersen, A., Holstein, B. E., Due, P., & Hansen, E. H. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1748 · Cited by 37 · cited 1×
“Medication use for headache seems to track from adolescence into adulthood (50).”
BackgroundExperts’ opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta
Özge, A., Abu‐Arafeh, I., Gelfand, A. A., Goadsby, P. J., Cuvellier, J. C., Valeriani, M., Сергеев, А. В., Barlow, K. M., Uludüz, D., Yalın, O. Ö., et al. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0819-x · Cited by 36 · cited 1×
“Chronic headache and MOH epidemiology have been studied in few countries, and very little data are available on its prevalence among children (57).”
BackgroundPark, J., Moon, H., Kim, J.-M., Lee, K.-S., & Chu, M. K. (2014) · Journal of Clinical Neurology · doi:10.3988/jcn.2014.10.3.236 · Cited by 33
Treatment of medication overuse headache—A review
Munksgaard, S. B., Madsen, S. K., & Wienecke, T. (2019) · Acta Neurologica Scandinavica · doi:10.1111/ane.13074 · Cited by 33 · cited 1×
“Comorbidity and multimorbidity are important to explore because of the problems of polypharmacy and drug interactions (63,64).”
BackgroundCan we know the prevalence of MOH?
Steiner, T. J. (2014) · Cephalalgia · doi:10.1177/0333102414520768 · Cited by 26 · cited 1×
“Rather, the focus is on needs assessment, improvement of health-care policy, and resource allocation (54).”
BackgroundStress and medicine use for headache: does sense of coherence modify the association?
Koushede, V., Holstein, B. E., Andersen, A., & Hansen, E. H. (2010) · European Journal of Public Health · doi:10.1093/eurpub/ckq077 · Cited by 19 · cited 1×
“Young Danes with low SEP and high perceived stress seem to be at higher risk (51).”
Background
Research works printed but not linked: 3
- Mbewe E, 2015, J Headache Pain, 16, 515
- Dansk Hovedpine Selskab. Referenceprogram: Diagnostik og behandling af hovedpinesygdomme og ansigtssmerter, 2. udgave [Guidelines: Diagnosis and treatment of headache disorders and facial pain, 2nd edition]. Copenhagen: Dansk Hovedpine Selskab, 2010.
- Fangel S, 2007, Metode og Data, 93, 14
Cited by
Ashina, S., Terwindt, G. M., Steiner, T. J., Lee, M. J., Porreca, F., Tassorelli, C., Schwedt, T. J., Jensen, R. H., Diener, H.-C., & Lipton, R. B. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00415-0 · Cited by 213
Self-citationZobdeh, F., Kraiem, A. B., Attwood, M. M., Chubarev, V. N., Tarasov, V. V., Schiöth, H. B., & Mwinyi, J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15657 · Cited by 158
“A recent epidemiological populationbased study in Denmark reported a prevalence of 2% in 55,000 respondents (Westergaard et al., 2020).”
BackgroundKatsuki, M., Yamagishi, C., Matsumori, Y., Koh, A., Kawamura, S., Kashiwagi, K., Kito, T., Entani, A., Yamamoto, T., Ikeda, T., et al. (2022) · Neurological Sciences · doi:10.1007/s10072-021-05831-w · Cited by 61
Evidence-based guidelines for the pharmacological treatment of migraine
Ornello, R., Caponnetto, V., Ahmed, F., Al‐Khazali, H. M., Ambrosini, A., Ashina, S., Baraldi, C., Bellotti, A., Brighina, F., Calabresi, P., et al. (2025) · Cephalalgia · doi:10.1177/03331024241305381 · Cited by 97
The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update
Sun‐Edelstein, C., Rapoport, A. M., Rattanawong, W., & Srikiatkhachorn, A. (2021) · CNS Drugs · doi:10.1007/s40263-021-00818-9 · Cited by 49
Metadata
- Authors
- Westergaard, M. L., Lau, C. J., Allesøe, K., Gjendal, S. T., & Jensen, R. H.
- Affiliations
- Glostrup Hospital (DK)
- Frederiksberg Hospital (DK)
- Corresponding author
- Westergaard, Maria Lurenda
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 2019-09-15
- Volume
- 40
- Issue
- 1
- Pages
- 6-18
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W2974896636
- Cited by
- 44
- References
- 57
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 1
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Cephalalgia (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- TrygFonden
- Allergan
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
- Keywords
- chronic headache, medication overuse headache, prevalence, over-the-counter analgesics, paracetamol, opioid use, triptans, socioeconomic position, welfare recipients
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Denmark, Female, Health Surveys, Humans, Male, Middle Aged, Risk Factors, Prevalence, Headache Disorders, Headache Disorders, Secondary, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.